Publications/ PresentationsAdnexus creates novel medicines using a proprietary class of biologics called Adnectins™. Please use this presentations & publications section to obtain further details on our Adnectin class, PROfusion protein engine, and the medicines we aim to create. 2008 ASCO Oral Presentation on CT-322 in Phase 1 2009 AACR Poster on EGFR - IGF1R Bispecific Adnectin 2009 AACR Poster on CT-322 + temozolomide |
Where are we speaking?In 2008, we delivered an oral presentation at ASCO discussing the Phase 1 data for CT-322, our lead Adnectin candidate. |